SCHEMBL2668158

SCHEMBL2668158

CC(C)(Cc1ccc(Cl)cc1)C(=O)Nc1nccs1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR2 O15552 8/20 0.62
▸ KDM4E B2RXH2 2/20 0.60
▸ POLB P06746 1/20 0.60
▸ CYP1A2 P05177 2/20 0.56
▸ CYP2D6 P10635 2/20 0.56
▸ CYP2C9 P11712 2/20 0.56
▸ CYP2C19 P33261 2/20 0.56
▸ CYP3A4 P08684 1/20 0.56
▸ MEN1 O00255 5/20 0.54
▸ KMT2A Q03164 5/20 0.54
▸ SMN1; SMN2 Q16637 3/20 0.54
▸ MAPT P10636 2/20 0.54
▸ CASP3 P42574 1/20 0.54
▸ HTT P42858 1/20 0.54
▸ SENP8 Q96LD8 1/20 0.54
▸ SENP7 Q9BQF6 1/20 0.54
▸ SENP6 Q9GZR1 1/20 0.54
▸ LMNA P02545 3/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ NPC1 O15118 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28267268 0.79 MEN1 (0.57) KDM4EPOLBMEN1KMT2ASMN1; SMN2
SCHEMBL14420964 0.78 MEN1 (0.67) MEN1KMT2ASMN1; SMN2MAPTHTT
SCHEMBL2658687 0.77 ALDH1A1 (0.64) FFAR2KDM4EPOLBCYP1A2CYP2D6
SCHEMBL1464767 0.76 MAPT (0.57) FFAR2CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL14417062 0.74 MEN1 (0.55) FFAR2MEN1KMT2ASMN1; SMN2MAPT
SCHEMBL592704 0.74 MEN1 (0.65) MEN1KMT2ASMN1; SMN2MAPTHTT
SCHEMBL2655802 0.73 NPC1 (0.49) FFAR2KDM4EPOLBCYP1A2CYP2D6
SCHEMBL2901112 0.73 NR3C1 (0.86) —
SCHEMBL2656574 0.73 MEN1 (0.63) MEN1KMT2ASMN1; SMN2MAPTHTT
SCHEMBL14532379 0.72 POLB (0.51) FFAR2KDM4EPOLBCYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008104994-A2 2,2,2-TRI-SUBSTITUTED ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2008-09-04 — — WO disclosed
Send feedback